News

Superannuation - Cooper review

The Cooper Review into superannuation was recently commission by the Federal Government.

The report has made recommendations for a significant shake up of the superannuation industry, and some of these changes affect people with a disability.

Maurice Blackburn Lawyers has released an information kit about the review. Click here to read it in full.

Group find MicroRNA changes in MS

Two microRNAs (miRNAs) thought to regulate immune genes are found at lower levels in the blood of those with MS than in unaffected individuals.

Researchers found lower expression of two miRNAs — miR-17 and miR-20a — in individuals with relapsing-remitting, secondary-progressive and primary-progressive MS.

Retrovirus study results

A decade-long study confirms the presence of multiple sclerosis-associated retrovirus in people with secondary-progressive MS.

Italian researchers recruited 39 untreated people with MS for a blind observational study in 1999. Patients were tested for MS-associated retrovirus in their cerebral spinal fluid.

MSRV proteins may trigger an abnormal immune response, influencing the inflammatory processes characteristic in MS. While the study has not demonstrated that MSRV causes MS, it could be a way of identifying potential worsening outcomes.

Source: MS Research Australia

Information sessions

MS Australia – QLD will hold free information sessions for people newly diagnosed with multiple sclerosis in Brisbane and on the Gold Coast next month.

The seminars, hosted by MS professionals, will cover a number of topics from new treatments and therapies to navigating the healthcare system. This event would suit people who have recently received an MS diagnosis, and family or friends are welcome to attend.

Gold Coast session: September 7 from 6pm at Gold Coast Hospital. Click here for details.
Brisbane session: September 8 from 5.30pm at MS Queensland's Services department. Click here for details.

For more information, contact Tim O’Maley on 07 3840 0855. Please RSVP by September 3.

CCSVI Statement

MS Australia – QLD has published a statement regarding Chronic Cerebrospinal Venous Insufficiency (CCSVI). MS Australia has recognised a need within the community to know more about Chronic Cerebro-Spinal Venous Insufficiency (CCSVI) therapy.

MS Australia has been working with MSRA to assess and analyse the global data on CCSVI therapy and the progress of a clinical trial within Australia as part of a world-wide response. You can view the full statement on CCSVI here.

More Articles...